Skip to main content

Table 2 Duration of illness, clinical symptoms, and laboratory data in relation to depression

From: Impact of depression on quality of life in systemic lupus erythematosus patients

Variables Total
(N = 32)
Depressive group (N = 15) Non-depressive group (N = 17) P value
Duration of illness in years (mean ± SD) 6.34 ± 4.5 6.46 ± 5.54 6.23 ± 3.52 0.888
Clinical symptoms N (%)
Myalgia number N (%) 26 (81%) 13 (87.7%) 13 (76.5%) 0.392
Lupus headache N (%) 25 (78%) 13 (86.7%) 12 (70.6%) 0.254
Arthritis N (%) 22 (69%) 13 (86.7%) 9 (52.9%) 0.046
Alopecia N (%) 22 (69%) 10 (66.7%) 12 (70.6%) 0.555
Oral/nasal ulcers N (%) 22 (69%) 12 (80%) 11 (64.7%) 0.287
Malar rash N (%) 20 (63%) 10 (66.7%) 10 (58.8%) 0.464
Fever N (%) 24 (51%) 13 (86.7%) 11 (64.7%) 0.152
Vasculitis lesion N (%) 4 (13%) 2 (13.3%) 2 (11.8%) 0.650
Retinal disease N (%) 3 (9%) 2 (13.3%) 1 (5.9%) 0.452
Cerebrovascular stroke N (%) 3 (9%) 1 (6.7%) 2 (11.8%) 0.548
Laboratory data (mean ± SD)
Protein 24 h in urine (mean ± SD) 264.84 ± 227.7 231.7 ± 236.7 294.1 ± 222. 0.448
Blood platelets (mean ± SD) 259.9 ± 64.95 262.3 ± 70.4 257.9 ± 61.9 0.854
Blood WBCs (mean ± SD) 5.78 ± 2 5.9 ± 1.7 5.7 ± 2.4 0.830
Blood sugar (normal range 70–100 mg/dl (mean ± SD) 88.31 ± 14.22 92 ± 15.5 85.1 ± 12.6 0.172
SLEDAI-2K (mean ± SD) 19.34 ± 7.46 21.6 ± 5.36 17.32 ± 8.58 0.109
  1. SLEDAI-2K the Systemic Lupus Erythematosus Disease Activity Index-2k, WBCs white blood cells